Dynamics of anti-RBD (anti-receptor binding domain) levels in diabetes patients following the ChAdOx1 nCoV-19 vaccine (AZD1222) in the Thai population

The ChAdOx1 nCoV-19 vaccine (AZD1222) was used in Thailand during the early outbreak of coronavirus disease 2019 (COVID-19). A previous study showed a low immune response in diabetes patients after the first dose of the AZD1222 vaccine. Furthermore, humoral immune responses after the second vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirisreetreerux, Supamas, Porntharukchareon, Thachanun, Dechates, Bothamai, Rangsrisaeneepitak, Vimonsri, Therawit, Phonthip, Worawitchawong, Supanat, Sornsamdang, Gaidganok, Soonklang, Kamonwan, Tawinprai, Kriangkrai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361991/
https://www.ncbi.nlm.nih.gov/pubmed/37479776
http://dx.doi.org/10.1038/s41598-023-39114-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361991/
https://www.ncbi.nlm.nih.gov/pubmed/37479776
http://dx.doi.org/10.1038/s41598-023-39114-5

Ejemplares similares